AFAS
Acorn Financial Advisory Services’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $789K | Hold |
1,502
| – | – | 0.13% | 78 |
|
|
2025
Q1 | $953K | Sell |
1,502
-100
| -6% | -$63.4K | 0.17% | 68 |
|
|
2024
Q4 | $1.14M | Hold |
1,602
| – | – | 0.19% | 62 |
|
|
2024
Q3 | $1.68M | Sell |
1,602
-1
| -0.1% | -$1.05K | 0.3% | 37 |
|
|
2024
Q2 | $1.68M | Hold |
1,603
| – | – | 0.31% | 35 |
|
|
2024
Q1 | $1.54M | Buy |
1,603
+1
| +0.1% | +$962 | 0.29% | 43 |
|
|
2023
Q4 | $1.41M | Buy |
1,602
+2
| +0.1% | +$1.76K | 0.25% | 61 |
|
|
2023
Q3 | $1.32M | Hold |
1,600
| – | – | 0.24% | 63 |
|
|
2023
Q2 | $1.15M | Buy |
+1,600
| New | +$1.15M | 0.2% | 71 |
|